Single centric Non- Randomised open clinical trial Phase ll in Uratha Pitha Vatham (Essential Hypertension) with the Siddha medicine Athimathura chooranam among patients attending OPD at Government Siddha Medical College Hospital Chennai Chennai.,
Overview
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- N RAKSHANA
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- The outcome of this treatment will be as follows.The blood pressure reduction of 80% is taken as good,reduction in 50% is taken as moderate,20% reduction is taken as poor.
Overview
Brief Summary
Hypertension or high blood pressure is a chronic condition in which blood pressure in arteries is higher than the normal. This condition can put extra strain on the heart and circulatory system , which must work harder to circulate the blood. Hypertension is a major risk factor for variety of cardiovascular diseases , including coronary artery disease , heart failure ,stroke and peripheral vascular disease.
The aim of the study is the clinical management of Uratha Pitha Vatham (ESSENTIAL HYPERTENSION) with the siddha trial Medicine Athimathura Chooranam. Thus in Siddha system of Medicine , there are unique combination of medicines which have the solution to Hypertension. One such combination is Athimathura Chooranam which is mentioned in Pathartha Guna Vilakam. The hypothesis is created in such a way to evaluate the efficacy of Athimathura Chooranam in the management of Hypertension.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 59.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •ïƒ˜ Grade 1 SBP ≥140 mmHg and 159 mmHg DBP ≥90 mmHg and 99 mmHg  Grade 2 SBP ≥160 mmHg and 179mmHg DBP≥100 mmHg and 109mmHg.
Exclusion Criteria
- •ïƒ˜ Age above 60 yrs  Vulnerable Population.
- •ïƒ˜ Associated Serious Illness.
- •ïƒ˜ Grade III SBP ≥180 mmHg DBP ≥110 mmHg.
Outcomes
Primary Outcomes
The outcome of this treatment will be as follows.The blood pressure reduction of 80% is taken as good,reduction in 50% is taken as moderate,20% reduction is taken as poor.
Time Frame: 3 Months
Secondary Outcomes
- Reduction in Total Cholesterol levels(3 Months)
Investigators
Dr N Rakshana
Government Siddha Medical College,Arumbakkam